Table of Content

1 Study Coverage
1.1 VEGFA Antibody Product Introduction
1.2 Market by Type
1.2.1 Global VEGFA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global VEGFA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global VEGFA Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global VEGFA Antibody Revenue by Region
2.2.1 Global VEGFA Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global VEGFA Antibody Revenue by Region (2018-2024)
2.2.3 Global VEGFA Antibody Revenue by Region (2024-2029)
2.2.4 Global VEGFA Antibody Revenue Market Share by Region (2018-2029)
2.3 Global VEGFA Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global VEGFA Antibody Sales by Region
2.4.1 Global VEGFA Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global VEGFA Antibody Sales by Region (2018-2024)
2.4.3 Global VEGFA Antibody Sales by Region (2024-2029)
2.4.4 Global VEGFA Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global VEGFA Antibody Sales by Manufacturers
3.1.1 Global VEGFA Antibody Sales by Manufacturers (2018-2024)
3.1.2 Global VEGFA Antibody Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of VEGFA Antibody in 2022
3.2 Global VEGFA Antibody Revenue by Manufacturers
3.2.1 Global VEGFA Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global VEGFA Antibody Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by VEGFA Antibody Revenue in 2022
3.3 Global Key Players of VEGFA Antibody, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global VEGFA Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global VEGFA Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of VEGFA Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of VEGFA Antibody, Product Offered and Application
3.8 Global Key Manufacturers of VEGFA Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global VEGFA Antibody Sales by Type
4.1.1 Global VEGFA Antibody Historical Sales by Type (2018-2024)
4.1.2 Global VEGFA Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global VEGFA Antibody Sales Market Share by Type (2018-2029)
4.2 Global VEGFA Antibody Revenue by Type
4.2.1 Global VEGFA Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global VEGFA Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global VEGFA Antibody Revenue Market Share by Type (2018-2029)
4.3 Global VEGFA Antibody Price by Type
4.3.1 Global VEGFA Antibody Price by Type (2018-2024)
4.3.2 Global VEGFA Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global VEGFA Antibody Sales by Application
5.1.1 Global VEGFA Antibody Historical Sales by Application (2018-2024)
5.1.2 Global VEGFA Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global VEGFA Antibody Sales Market Share by Application (2018-2029)
5.2 Global VEGFA Antibody Revenue by Application
5.2.1 Global VEGFA Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global VEGFA Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global VEGFA Antibody Revenue Market Share by Application (2018-2029)
5.3 Global VEGFA Antibody Price by Application
5.3.1 Global VEGFA Antibody Price by Application (2018-2024)
5.3.2 Global VEGFA Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada VEGFA Antibody Market Size by Type
6.1.1 US & Canada VEGFA Antibody Sales by Type (2018-2029)
6.1.2 US & Canada VEGFA Antibody Revenue by Type (2018-2029)
6.2 US & Canada VEGFA Antibody Market Size by Application
6.2.1 US & Canada VEGFA Antibody Sales by Application (2018-2029)
6.2.2 US & Canada VEGFA Antibody Revenue by Application (2018-2029)
6.3 US & Canada VEGFA Antibody Market Size by Country
6.3.1 US & Canada VEGFA Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada VEGFA Antibody Sales by Country (2018-2029)
6.3.3 US & Canada VEGFA Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe VEGFA Antibody Market Size by Type
7.1.1 Europe VEGFA Antibody Sales by Type (2018-2029)
7.1.2 Europe VEGFA Antibody Revenue by Type (2018-2029)
7.2 Europe VEGFA Antibody Market Size by Application
7.2.1 Europe VEGFA Antibody Sales by Application (2018-2029)
7.2.2 Europe VEGFA Antibody Revenue by Application (2018-2029)
7.3 Europe VEGFA Antibody Market Size by Country
7.3.1 Europe VEGFA Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe VEGFA Antibody Sales by Country (2018-2029)
7.3.3 Europe VEGFA Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China VEGFA Antibody Market Size
8.1.1 China VEGFA Antibody Sales (2018-2029)
8.1.2 China VEGFA Antibody Revenue (2018-2029)
8.2 China VEGFA Antibody Market Size by Application
8.2.1 China VEGFA Antibody Sales by Application (2018-2029)
8.2.2 China VEGFA Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia VEGFA Antibody Market Size by Type
9.1.1 Asia VEGFA Antibody Sales by Type (2018-2029)
9.1.2 Asia VEGFA Antibody Revenue by Type (2018-2029)
9.2 Asia VEGFA Antibody Market Size by Application
9.2.1 Asia VEGFA Antibody Sales by Application (2018-2029)
9.2.2 Asia VEGFA Antibody Revenue by Application (2018-2029)
9.3 Asia VEGFA Antibody Sales by Region
9.3.1 Asia VEGFA Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia VEGFA Antibody Revenue by Region (2018-2029)
9.3.3 Asia VEGFA Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America VEGFA Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America VEGFA Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America VEGFA Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America VEGFA Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America VEGFA Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America VEGFA Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America VEGFA Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America VEGFA Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America VEGFA Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America VEGFA Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Information
11.1.2 Sino Biological, Inc. Overview
11.1.3 Sino Biological, Inc. VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sino Biological, Inc. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Abcam
11.2.1 Abcam Company Information
11.2.2 Abcam Overview
11.2.3 Abcam VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Abcam VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abcam Recent Developments
11.3 Thermo Fisher Scientific (China) Co., Ltd.
11.3.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
11.3.2 Thermo Fisher Scientific (China) Co., Ltd. Overview
11.3.3 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
11.4 Bio-Techne
11.4.1 Bio-Techne Company Information
11.4.2 Bio-Techne Overview
11.4.3 Bio-Techne VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bio-Techne VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio-Techne Recent Developments
11.5 BioLegend
11.5.1 BioLegend Company Information
11.5.2 BioLegend Overview
11.5.3 BioLegend VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 BioLegend VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioLegend Recent Developments
11.6 LifeSpan BioSciences, Inc
11.6.1 LifeSpan BioSciences, Inc Company Information
11.6.2 LifeSpan BioSciences, Inc Overview
11.6.3 LifeSpan BioSciences, Inc VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 LifeSpan BioSciences, Inc VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LifeSpan BioSciences, Inc Recent Developments
11.7 Elabscience Biotechnology Inc.
11.7.1 Elabscience Biotechnology Inc. Company Information
11.7.2 Elabscience Biotechnology Inc. Overview
11.7.3 Elabscience Biotechnology Inc. VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Elabscience Biotechnology Inc. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Elabscience Biotechnology Inc. Recent Developments
11.8 Boster Biological Technology
11.8.1 Boster Biological Technology Company Information
11.8.2 Boster Biological Technology Overview
11.8.3 Boster Biological Technology VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Boster Biological Technology VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boster Biological Technology Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Wuhan Fine Biotech Co., Ltd.
11.10.1 Wuhan Fine Biotech Co., Ltd. Company Information
11.10.2 Wuhan Fine Biotech Co., Ltd. Overview
11.10.3 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
11.11 ProSci Incorporated
11.11.1 ProSci Incorporated Company Information
11.11.2 ProSci Incorporated Overview
11.11.3 ProSci Incorporated VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 ProSci Incorporated VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ProSci Incorporated Recent Developments
11.12 Abbexa
11.12.1 Abbexa Company Information
11.12.2 Abbexa Overview
11.12.3 Abbexa VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Abbexa VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbexa Recent Developments
11.13 Miltenyi Biotec
11.13.1 Miltenyi Biotec Company Information
11.13.2 Miltenyi Biotec Overview
11.13.3 Miltenyi Biotec VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Miltenyi Biotec VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Miltenyi Biotec Recent Developments
11.14 Arigo Biolaboratories Corp.
11.14.1 Arigo Biolaboratories Corp. Company Information
11.14.2 Arigo Biolaboratories Corp. Overview
11.14.3 Arigo Biolaboratories Corp. VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Arigo Biolaboratories Corp. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Arigo Biolaboratories Corp. Recent Developments
11.15 Assay Genie
11.15.1 Assay Genie Company Information
11.15.2 Assay Genie Overview
11.15.3 Assay Genie VEGFA Antibody Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Assay Genie VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Assay Genie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 VEGFA Antibody Industry Chain Analysis
12.2 VEGFA Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 VEGFA Antibody Production Mode & Process
12.4 VEGFA Antibody Sales and Marketing
12.4.1 VEGFA Antibody Sales Channels
12.4.2 VEGFA Antibody Distributors
12.5 VEGFA Antibody Customers
13 Market Dynamics
13.1 VEGFA Antibody Industry Trends
13.2 VEGFA Antibody Market Drivers
13.3 VEGFA Antibody Market Challenges
13.4 VEGFA Antibody Market Restraints
14 Key Findings in The Global VEGFA Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global VEGFA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Polyclonal Antibody
Table 4. Global VEGFA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global VEGFA Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global VEGFA Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global VEGFA Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global VEGFA Antibody Revenue Market Share by Region (2018-2024)
Table 9. Global VEGFA Antibody Revenue Market Share by Region (2024-2029)
Table 10. Global VEGFA Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global VEGFA Antibody Sales by Region (2018-2024) & (K Units)
Table 12. Global VEGFA Antibody Sales by Region (2024-2029) & (K Units)
Table 13. Global VEGFA Antibody Sales Market Share by Region (2018-2024)
Table 14. Global VEGFA Antibody Sales Market Share by Region (2024-2029)
Table 15. Global VEGFA Antibody Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global VEGFA Antibody Sales Share by Manufacturers (2018-2024)
Table 17. Global VEGFA Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global VEGFA Antibody Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of VEGFA Antibody, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. VEGFA Antibody Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global VEGFA Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global VEGFA Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VEGFA Antibody as of 2022)
Table 23. Global Key Manufacturers of VEGFA Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of VEGFA Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of VEGFA Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 28. Global VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 29. Global VEGFA Antibody Sales Share by Type (2018-2024)
Table 30. Global VEGFA Antibody Sales Share by Type (2024-2029)
Table 31. Global VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global VEGFA Antibody Revenue Share by Type (2018-2024)
Table 34. Global VEGFA Antibody Revenue Share by Type (2024-2029)
Table 35. VEGFA Antibody Price by Type (2018-2024) & (US$/Unit)
Table 36. Global VEGFA Antibody Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 38. Global VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 39. Global VEGFA Antibody Sales Share by Application (2018-2024)
Table 40. Global VEGFA Antibody Sales Share by Application (2024-2029)
Table 41. Global VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global VEGFA Antibody Revenue Share by Application (2018-2024)
Table 44. Global VEGFA Antibody Revenue Share by Application (2024-2029)
Table 45. VEGFA Antibody Price by Application (2018-2024) & (US$/Unit)
Table 46. Global VEGFA Antibody Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada VEGFA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada VEGFA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada VEGFA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada VEGFA Antibody Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada VEGFA Antibody Sales by Country (2024-2029) & (K Units)
Table 60. Europe VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 61. Europe VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 62. Europe VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 65. Europe VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 66. Europe VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe VEGFA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe VEGFA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe VEGFA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe VEGFA Antibody Sales by Country (2018-2024) & (K Units)
Table 72. Europe VEGFA Antibody Sales by Country (2024-2029) & (K Units)
Table 73. China VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 74. China VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 75. China VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 76. China VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 77. China VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 78. China VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 79. China VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 80. China VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 82. Asia VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 83. Asia VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 86. Asia VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 87. Asia VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia VEGFA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia VEGFA Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia VEGFA Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia VEGFA Antibody Sales by Region (2018-2024) & (K Units)
Table 93. Asia VEGFA Antibody Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America VEGFA Antibody Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America VEGFA Antibody Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America VEGFA Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America VEGFA Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America VEGFA Antibody Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America VEGFA Antibody Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America VEGFA Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America VEGFA Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America VEGFA Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America VEGFA Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America VEGFA Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America VEGFA Antibody Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America VEGFA Antibody Sales by Country (2024-2029) & (K Units)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Description and Major Businesses
Table 109. Sino Biological, Inc. VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sino Biological, Inc. Recent Developments
Table 112. Abcam Company Information
Table 113. Abcam Description and Major Businesses
Table 114. Abcam VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Abcam VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abcam Recent Developments
Table 117. Thermo Fisher Scientific (China) Co., Ltd. Company Information
Table 118. Thermo Fisher Scientific (China) Co., Ltd. Description and Major Businesses
Table 119. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
Table 122. Bio-Techne Company Information
Table 123. Bio-Techne Description and Major Businesses
Table 124. Bio-Techne VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Bio-Techne VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bio-Techne Recent Developments
Table 127. BioLegend Company Information
Table 128. BioLegend Description and Major Businesses
Table 129. BioLegend VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. BioLegend VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. BioLegend Recent Developments
Table 132. LifeSpan BioSciences, Inc Company Information
Table 133. LifeSpan BioSciences, Inc Description and Major Businesses
Table 134. LifeSpan BioSciences, Inc VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. LifeSpan BioSciences, Inc VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. LifeSpan BioSciences, Inc Recent Developments
Table 137. Elabscience Biotechnology Inc. Company Information
Table 138. Elabscience Biotechnology Inc. Description and Major Businesses
Table 139. Elabscience Biotechnology Inc. VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Elabscience Biotechnology Inc. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Elabscience Biotechnology Inc. Recent Developments
Table 142. Boster Biological Technology Company Information
Table 143. Boster Biological Technology Description and Major Businesses
Table 144. Boster Biological Technology VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Boster Biological Technology VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Boster Biological Technology Recent Developments
Table 147. Merck Company Information
Table 148. Merck Description and Major Businesses
Table 149. Merck VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Merck VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merck Recent Developments
Table 152. Wuhan Fine Biotech Co., Ltd. Company Information
Table 153. Wuhan Fine Biotech Co., Ltd. Description and Major Businesses
Table 154. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 157. ProSci Incorporated Company Information
Table 158. ProSci Incorporated Description and Major Businesses
Table 159. ProSci Incorporated VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. ProSci Incorporated VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. ProSci Incorporated Recent Developments
Table 162. Abbexa Company Information
Table 163. Abbexa Description and Major Businesses
Table 164. Abbexa VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Abbexa VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Abbexa Recent Developments
Table 167. Miltenyi Biotec Company Information
Table 168. Miltenyi Biotec Description and Major Businesses
Table 169. Miltenyi Biotec VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Miltenyi Biotec VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Miltenyi Biotec Recent Developments
Table 172. Arigo Biolaboratories Corp. Company Information
Table 173. Arigo Biolaboratories Corp. Description and Major Businesses
Table 174. Arigo Biolaboratories Corp. VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Arigo Biolaboratories Corp. VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Arigo Biolaboratories Corp. Recent Developments
Table 177. Assay Genie Company Information
Table 178. Assay Genie Description and Major Businesses
Table 179. Assay Genie VEGFA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Assay Genie VEGFA Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Assay Genie Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. VEGFA Antibody Distributors List
Table 185. VEGFA Antibody Customers List
Table 186. VEGFA Antibody Market Trends
Table 187. VEGFA Antibody Market Drivers
Table 188. VEGFA Antibody Market Challenges
Table 189. VEGFA Antibody Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. VEGFA Antibody Product Picture
Figure 2. Global VEGFA Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global VEGFA Antibody Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Polyclonal Antibody Product Picture
Figure 6. Global VEGFA Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global VEGFA Antibody Market Share by Application in 2022 & 2029
Figure 8. Flow Cytometry
Figure 9. ELISA
Figure 10. Western Blot
Figure 11. Immunoprecipitation
Figure 12. Immunofluorescence
Figure 13. Others
Figure 14. VEGFA Antibody Report Years Considered
Figure 15. Global VEGFA Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global VEGFA Antibody Revenue 2018-2029 (US$ Million)
Figure 17. Global VEGFA Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global VEGFA Antibody Revenue Market Share by Region (2018-2029)
Figure 19. Global VEGFA Antibody Sales 2018-2029 ((K Units)
Figure 20. Global VEGFA Antibody Sales Market Share by Region (2018-2029)
Figure 21. US & Canada VEGFA Antibody Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada VEGFA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe VEGFA Antibody Sales YoY (2018-2029) & (K Units)
Figure 24. Europe VEGFA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China VEGFA Antibody Sales YoY (2018-2029) & (K Units)
Figure 26. China VEGFA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) VEGFA Antibody Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) VEGFA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America VEGFA Antibody Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America VEGFA Antibody Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The VEGFA Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of VEGFA Antibody in the World: Market Share by VEGFA Antibody Revenue in 2022
Figure 33. Global VEGFA Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 35. Global VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 36. Global VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 37. Global VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 39. US & Canada VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 41. US & Canada VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada VEGFA Antibody Revenue Share by Country (2018-2029)
Figure 43. US & Canada VEGFA Antibody Sales Share by Country (2018-2029)
Figure 44. U.S. VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 45. Canada VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 46. Europe VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 47. Europe VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 48. Europe VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 49. Europe VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 50. Europe VEGFA Antibody Revenue Share by Country (2018-2029)
Figure 51. Europe VEGFA Antibody Sales Share by Country (2018-2029)
Figure 52. Germany VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 53. France VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 55. Italy VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 56. Russia VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 57. China VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 58. China VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 59. China VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 60. China VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 61. Asia VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 62. Asia VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 63. Asia VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 64. Asia VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 65. Asia VEGFA Antibody Revenue Share by Region (2018-2029)
Figure 66. Asia VEGFA Antibody Sales Share by Region (2018-2029)
Figure 67. Japan VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 71. India VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America VEGFA Antibody Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America VEGFA Antibody Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America VEGFA Antibody Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America VEGFA Antibody Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America VEGFA Antibody Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America VEGFA Antibody Sales Share by Country (2018-2029)
Figure 78. Brazil VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 81. Israel VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries VEGFA Antibody Revenue (2018-2029) & (US$ Million)
Figure 83. VEGFA Antibody Value Chain
Figure 84. VEGFA Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed